Guo-Ping Shi Selected Research

Peripheral Arterial Disease

12/2018	Plasma Cystatin B Association With Abdominal Aortic Aneurysms and Need for Later Surgical Repair: A Sub-study of the VIVA Trial.
9/2013	Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study.
1/2012	Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Ping Shi Research Topics

Disease

44	Atherosclerosis 01/2024 - 03/2003
37	Abdominal Aortic Aneurysm 01/2024 - 02/2006
31	Inflammation (Inflammations) 04/2024 - 02/2006
21	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 03/2003
14	Fibrosis (Cirrhosis) 01/2024 - 08/2008
13	Obesity 09/2023 - 12/2008
11	Myocardial Infarction 01/2023 - 06/2006
10	Body Weight (Weight, Body) 01/2020 - 08/2007
8	Neoplasms (Cancer) 01/2022 - 03/2006
7	Insulin Resistance 09/2023 - 10/2012
6	Hypertension (High Blood Pressure) 01/2022 - 11/2006
6	Vascular Remodeling 01/2021 - 01/2004
6	Atherosclerotic Plaque (Atheroma) 01/2020 - 02/2005
5	Infarction (Infarctions) 01/2023 - 01/2012
5	Cardiomegaly (Heart Hypertrophy) 01/2023 - 02/2013
5	Glucose Intolerance 01/2022 - 08/2007
5	Coronary Disease (Coronary Heart Disease) 12/2020 - 02/2009
5	Hyperplasia 01/2020 - 01/2016
5	Aneurysm (Aneurysms) 01/2020 - 11/2006
5	Heart Failure 01/2018 - 11/2006
5	Vascular Diseases (Vascular Disease) 11/2014 - 02/2006
4	Infections 09/2023 - 12/2008
4	Hypertrophy 01/2023 - 11/2006
4	Hypoxia (Hypoxemia) 12/2020 - 07/2010
4	Asthma (Bronchial Asthma) 01/2020 - 01/2016
4	Pneumonia (Pneumonitis) 11/2019 - 01/2016
4	Disease Progression 01/2018 - 04/2009
4	Rupture 03/2016 - 06/2011
3	Thrombosis (Thrombus) 05/2024 - 05/2013
3	Metabolic Diseases (Metabolic Disease) 09/2023 - 12/2011
3	COVID-19 09/2023 - 01/2020
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2023 - 11/2015
3	Colitis 03/2023 - 11/2019
3	Aortic Aneurysm (Aneurysm, Aortic) 01/2022 - 11/2006
3	Neointima 12/2019 - 01/2004
3	Ischemia 11/2019 - 08/2010
3	Ventricular Remodeling 01/2019 - 10/2014
3	Peripheral Arterial Disease 12/2018 - 01/2012
3	Rheumatoid Arthritis 01/2018 - 05/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 06/2009
3	Pathologic Constriction (Stenosis) 11/2011 - 02/2006
3	Unstable Angina 09/2011 - 06/2006
2	Ischemic Stroke 11/2023 - 08/2019
2	Muscular Atrophy (Muscle Atrophy) 08/2023 - 01/2022
2	Hyperglycemia 01/2022 - 12/2011

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2004
24	CathepsinsIBA 01/2020 - 01/2004
21	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 03/2003
18	cathepsin SIBA 08/2023 - 03/2003
18	Cysteine Proteases (Cysteine Protease)IBA 01/2018 - 01/2004
17	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 06/2006
16	Cathepsin KIBA 05/2024 - 03/2007
15	Apolipoproteins E (ApoE)IBA 01/2020 - 02/2005
13	CytokinesIBA 03/2023 - 03/2003
12	Angiotensin IIIBA 01/2024 - 03/2010
12	Immunoglobulin E (IgE)IBA 01/2020 - 01/2011
11	Cystatin CIBA 11/2023 - 03/2003
10	ApolipoproteinsIBA 12/2017 - 02/2005
9	Biomarkers (Surrogate Marker)IBA 02/2020 - 06/2006
9	ElastinIBA 05/2016 - 01/2004
8	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 08/2004
8	LDL Receptors (LDL Receptor)IBA 11/2014 - 03/2003
7	CollagenIBA 01/2023 - 04/2007
7	CholesterolIBA 01/2020 - 03/2003
7	Cathepsin LIBA 01/2020 - 02/2006
7	Chymases (Chymase)IBA 01/2019 - 09/2009
7	Tryptases (Tryptase)IBA 01/2013 - 01/2011
6	Interleukin-6 (Interleukin 6)IBA 04/2024 - 06/2007
6	Insulin (Novolin)FDA Link 12/2022 - 03/2006
5	Interleukin-18 (Interleukin 18)IBA 01/2024 - 07/2015
5	ChemokinesIBA 03/2023 - 08/2009
5	LipidsIBA 01/2020 - 02/2005
4	SaltsIBA 03/2023 - 07/2009
4	Toll-Like Receptor 2IBA 01/2022 - 03/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2019 - 03/2006
4	InterleukinsIBA 01/2018 - 06/2007
4	Protease Inhibitors (Protease Inhibitor)IBA 01/2013 - 02/2005
4	Pancreatic Elastase (Elastase)IBA 01/2012 - 11/2007
4	EnzymesIBA 09/2011 - 08/2004
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2023 - 11/2015
3	Interleukin-5 (Interleukin 5)IBA 01/2023 - 01/2016
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 03/2011
3	Complement System Proteins (Complement)IBA 01/2017 - 02/2009
3	Serine Proteases (Serine Protease)IBA 12/2015 - 08/2004
3	Interleukin-17 (Interleukin 17)IBA 10/2014 - 06/2009
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2011 - 02/2006
2	Cysteine (L-Cysteine)FDA Link 05/2024 - 03/2006
2	IronIBA 05/2024 - 01/2023
2	wumeiIBA 04/2024 - 03/2023
2	TOR Serine-Threonine KinasesIBA 08/2023 - 06/2013
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2023 - 08/2010
2	Interleukin-4 (Interleukin 4)IBA 01/2023 - 12/2020
2	Eosinophil Cationic ProteinIBA 01/2023 - 01/2021
2	Interleukin-13IBA 01/2023 - 01/2016
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 01/2019
2	Caspase 8 (Caspase-8)IBA 01/2022 - 12/2019

Therapy/Procedure

11	Therapeutics 03/2023 - 04/2009
3	Ligation 01/2018 - 03/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 01/2020